Archives
- 2026-05
- 2026-04
- 2026-03
- 2026-02
- 2026-01
- 2025-12
- 2025-11
- 2025-10
- 2025-09
- 2025-04
- 2025-03
- 2025-02
- 2025-01
- 2024-12
- 2024-11
- 2024-10
- 2024-09
- 2024-08
- 2024-07
- 2024-06
- 2024-05
- 2024-04
- 2024-03
- 2024-02
- 2024-01
- 2023-12
- 2023-11
- 2023-10
- 2023-09
- 2023-08
- 2023-07
- 2023-06
- 2023-05
- 2023-04
- 2023-03
- 2023-02
- 2023-01
- 2022-12
- 2022-11
- 2022-10
- 2022-09
- 2022-08
- 2022-07
- 2022-06
- 2022-05
- 2022-04
- 2022-03
- 2022-02
- 2022-01
- 2021-12
- 2021-11
- 2021-10
- 2021-09
- 2021-08
- 2021-07
- 2021-06
- 2021-05
- 2021-04
- 2021-03
- 2021-02
- 2021-01
- 2020-12
- 2020-11
- 2020-10
- 2020-09
- 2020-08
- 2020-07
- 2020-06
- 2020-05
- 2020-04
- 2020-03
- 2020-02
- 2020-01
- 2019-12
- 2019-11
- 2019-10
- 2019-09
- 2019-08
- 2019-07
- 2019-06
- 2019-05
- 2019-04
- 2018-07
-
Disrupting PD-L1 Recycling in Myeloid Cells Boosts T-Cell Ex
2026-05-01
This study introduces a novel anti-PD-L1 antibody (H1A) that targets PD-L1 recycling and degradation in myeloid cells, overcoming key limitations of current checkpoint inhibitors. By redirecting PD-L1 for degradation, H1A enhances myeloid cell activation and expands cytotoxic T-cell populations, offering a new strategy to improve immune responses in cancers resistant to existing therapies.
-
Tacrolimus (FK506): Precision in Translational Immune Modula
2026-05-01
Discover how Tacrolimus (FK506) enables highly selective and potent immune response suppression for translational researchers. This article integrates mechanistic insights, protocol guidance, and strategic comparisons—highlighting APExBIO's Tacrolimus (FK506) as the platform of choice for advanced transplantation immunology research and autoimmune disease models.
-
FOXM1–ERα ceRNA Network in Female Lung Adenocarcinoma: Insig
2026-04-30
This study uncovers a novel ceRNA network involving FOXM1 and estrogen receptor alpha (ERα) in female lung adenocarcinoma (LUAD), integrating large-scale transcriptomic analyses and in vitro validation. These findings provide mechanistic insight into LUAD progression and suggest new biomarker and therapeutic avenues for hormone receptor-driven lung cancer.
-
PPM-18 Unlocks Precision iNOS Inhibition in Sepsis Research
2026-04-30
PPM-18 (N-(1,4-dihydro-1,4-dioxo-2-naphthalenyl)-benzamide) enables highly selective NF-κB pathway inhibition for advanced sepsis and inflammation models. Its unique mechanism allows researchers to dissect iNOS regulation with unprecedented reproducibility and workflow flexibility.
-
MOG (35-55) Peptide: Molecular Control Points in EAE and MS
2026-04-29
Explore the molecular intricacies of MOG (35-55), a myelin oligodendrocyte glycoprotein peptide, as a precision tool in autoimmune encephalomyelitis research. This article uniquely bridges mechanistic immunology and assay optimization, providing advanced insights for multiple sclerosis research.
-
Balsalazide Disodium: Applied Protocols in Inflammation Rese
2026-04-29
Balsalazide Disodium Dihydrate empowers precise modeling of ulcerative colitis and targeted inflammation workflows, with robust radiolabeling and immunology assay compatibility. Discover actionable protocol enhancements and troubleshooting strategies to maximize reproducibility in preclinical and translational inflammation research.
-
JNK-IN-7 as a Precision Tool for Dissecting JNK-ERK Pathways
2026-04-28
Explore how JNK-IN-7, a selective JNK inhibitor, uniquely enables advanced mechanistic research into apoptosis and innate immune signaling. This article provides a deep, assay-focused perspective distinct from previous analyses.
-
Immunoproteasome Activation Enables Human TRIM5α HIV-1 Restr
2026-04-28
Jimenez-Guardeño et al. (2019) demonstrate that activation of the immunoproteasome by interferon-α reprograms human TRIM5α, enabling it to restrict HIV-1 infection—a function previously thought to be absent in humans. This finding clarifies a novel antiviral mechanism with implications for both innate immunity research and targeted therapeutic development.
-
Imatinib Hydrochloride: Optimizing Tyrosine Kinase Inhibitio
2026-04-27
Imatinib hydrochloride (STI571 hydrochloride) empowers researchers to dissect oncogenic tyrosine kinase signaling with precision. This guide delivers actionable protocols, advanced troubleshooting, and workflow innovations for chronic myelogenous leukemia and gastrointestinal stromal tumor research—leveraging both classic and novel mechanistic insights.
-
PTK6-SOCS3-mTOR Axis Regulates Autophagy in Uveal Melanoma
2026-04-27
This study uncovers how PTK6 promotes uveal melanoma progression by binding to SOCS3 and enhancing mTOR phosphorylation, thus inhibiting autophagy. These findings clarify a novel regulatory mechanism and suggest that targeting the PTK6-SOCS3-mTOR axis could offer new therapeutic strategies for uveal melanoma.
-
Lenalidomide (CC-5013): Workflow Optimization in Myeloma Res
2026-04-26
Deploy Lenalidomide (CC-5013) as a potent immune system activation agent and angiogenesis inhibitor in translational multiple myeloma research. This guide bridges mechanistic breakthroughs with stepwise protocols and troubleshooting, maximizing reliability and interpretability in advanced cancer immunology workflows.
-
Urolithin A: Mitochondrial Biogenesis and Glutamine Metaboli
2026-04-25
Explore how Urolithin A, a gut microbiota-derived metabolite, advances mitochondrial biogenesis research and modulates glutamine metabolism. This article uniquely dissects its mechanistic roles and protocol implications for liver fibrosis and cellular studies.
-
Uremic Toxins Alter Protein Adsorption on PEO-Coated Surface
2026-04-24
This study demonstrates that common uremic toxins, including 4-ethylphenyl sulfate, significantly increase plasma protein adsorption on poly(ethylene oxide) (PEO)-modified surfaces, overriding the protective effects of PEO chain density. These findings highlight the need to account for disease-specific blood composition in biomaterial design, particularly for patients with renal dysfunction.
-
KR-12 Human Antimicrobial Peptide: Workflows & Biofilm Contr
2026-04-24
KR-12, the smallest LL-37 fragment, offers targeted antimicrobial and anti-biofilm action against multidrug-resistant pathogens with low mammalian cytotoxicity. This guide translates bench research into actionable protocols and troubleshooting strategies for maximizing KR-12's research impact.
-
Thermal Shift Assays Reveal Ligands for Bacterial Sensor Pro
2026-04-23
This review synthesizes advances in using thermal shift assays to identify ligands for bacterial sensor proteins, detailing technical refinements and experimental considerations. The findings enhance understanding of bacterial signaling and offer methodological guidance for high-throughput ligand discovery and target validation.